Titel

Merkliste
1 Ergebnisse

Phase I trial of the MEK inhibitor selumetinib in combinati..:

Haslett, K ; Koh, P ; Hudson, A...
Haslett , K , Koh , P , Hudson , A , Ryder , W D , Falk , S , Mullan , D , Taylor , B , Califano , R , Blackhall , F & Faivre-finn , C 2021 , ' Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer ' , Clinical and translational radiation oncology . https://doi.org/10.1016/j.ctro.2021.02.008. , 2021

Link: https://research.manchester.ac.uk/en/publications/f26c..

RT Journal
T1 <Title>Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftumanchesterpub:oai:pure.atira.dk:publications_f26c057b-9e30-4703-b620-5058ebd28f7d&Exemplar=1&LAN=DE
				
A1 Haslett, K
A1 Koh, P
A1 Hudson, A
A1 Ryder, W.d
A1 Falk, S
A1 Mullan, D
A1 Taylor, B
A1 Califano, R
A1 Blackhall, F
A1 Faivre-finn, C
YR 2021
K1 ResearchInstitutes_Networks_Beacons/mcrc
K1 Manchester Cancer Research Centre
JF Haslett , K , Koh , P , Hudson , A , Ryder , W D , Falk , S , Mullan , D , Taylor , B , Califano , R , Blackhall , F & Faivre-finn , C 2021 , ' Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer ' , Clinical and translational radiation oncology . https://doi.org/10.1016/j.ctro.2021.02.008
LK http://dx.doi.org/https://research.manchester.ac.uk/en/publications/f26c057b-9e30-4703-b620-5058ebd28f7d
DO https://research.manchester.ac.uk/en/publications/f26c057b-9e30-4703-b620-5058ebd28f7d
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)